The Association Between the Distributions MCH and RBC, and Mortality in Hemodialysis Patients
NCT04227158 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 437
Last updated 2020-11-04
Summary
Patients were classified into two groups based on the values of MCH and RBC, patients with MCH ≥30 pg but \<35 pg and RBC ≤350×104/μL; and MCH \<30 pg and RBC \>350×104/μL. Associations between all-cause mortality and the distributions of MCH and RBC were assessed by Kaplan-Meier curves and Cox proportional hazards regression model.
Conditions
- Renal Anemia
Sponsors & Collaborators
-
University of Hyogo
lead OTHER
Principal Investigators
-
Yuko MIZUNO, Ph.D. · University of Hyogo
Eligibility
- Min Age
- 40 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-20
- Primary Completion
- 2020-08-20
- Completion
- 2020-08-20
Countries
- Japan
Study Locations
More Related Trials
-
Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
NCT00994318 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney Disease
NCT03643601 ·Status: COMPLETED
-
Mean Reticulated Haemoglobin (Hb) Content (RetHe) Analysis of Renal Patients
NCT01126905 ·Status: COMPLETED
-
Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
NCT02185911 ·Status: COMPLETED
-
Renal Anemia Refractory to Erythropoietin
NCT03480178 ·Status: UNKNOWN
-
Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients
NCT05032651 ·Status: UNKNOWN ·Phase: NA
-
Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
NCT00317226 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
NCT01977573 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia
NCT02791763 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of NeoRecormon in Patients With Chronic Kidney Disease.
NCT00437723 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
NCT00440063 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug
NCT01888445 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects
NCT03350321 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Reticulocyte Hemoglobin and Transferrin Saturation to Guide Iron Treatment in People on Dialysis
NCT06906835 ·Status: RECRUITING ·Phase: NA
-
Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients
NCT00478582 ·Status: COMPLETED ·Phase: NA
-
A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia
NCT02952092 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients
NCT00261521 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease
NCT00925587 ·Status: COMPLETED ·Phase: PHASE3
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients
NCT00233597 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents
NCT02829320 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)
NCT01017627 ·Status: UNKNOWN ·Phase: NA
-
Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia
NCT00517881 ·Status: TERMINATED ·Phase: PHASE3
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
NCT00255437 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia
NCT02780141 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients
NCT02198495 ·Status: COMPLETED ·Phase: PHASE4